1. Tumor-mediated immunosuppression is a challenge in cancer treatment

   • A. A. Hakim

   Guest Editorial Pages: 1 - 6

2. Interferons as cell-regulatory molecules

   • F. R. Balkwill

   Review Pages: 7 - 14

3. Improvement of monocyte chemotaxis with BCG immunotherapy in acute lymphoblastic leukemia: Comparison of chemotherapy versus chemotherapy plus immunotherapy as therapeutic regimens

   • D. A. Norris
   • W. L. Weston
   • Lorrie F. Odom

   Original Articles Pages: 15 - 18

4. Studies of lymphocyte stimulation to tumor-associated antigen

   • J. A. Roth
   • D. L. Morton

   Original Articles Pages: 19 - 23

5. Studies of lymphocyte stimulation to tumor-associated antigen

   • J. A. Roth
   • D. O. Chee
   • D. L. Morton

   Original Articles Pages: 25 - 29

6. Immunoprophylaxis with attenuated ehrlich ascites tumor cells in admixture with BCG

   • R. Turcotte

   Original Articles Pages: 31 - 35

7. Hypothesis: Non-hodgkin lymphomas are abnormal immune responses

   • J. A. Habeshaw

   Original Articles Pages: 37 - 42

8. Peptides as requirement for immunotherapy of the guinea-pig line-10 tumor with endotoxins

   • E. Ribi
   • R. Parker
   • M. B. Goren

   Original Articles Pages: 43 - 58

9. Tumour-associated antigens in culture medium of malignant melanoma cell strains

   • R. Jacubovich
   • J.-F. Doré

   Original Articles Pages: 59 - 64

10. Spontaneous cell-mediated cytotoxicity (SCMC) and antibody-dependent cellular cytotoxicity (ADCC) in peripheral blood and draining lymph nodes of patients with mammary carcinoma

    • W. Heidenreich
    • K. Jagla
    • H. Deicher

    Original Articles Pages: 65 - 69